Mahesh N Samtani

Mahesh N Samtani

Johnson & Johnson Co. - New Jersey / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4386332
-
person_outline Mahesh N Samtani's MOST POPULAR ARTICLES
1-) Population pharmacokinetics of intramuscular paliperidone palmitate in patients with schizophreniaMN Samtani, A Vermeulen, K StuyckensClinical pharmacokinetics 48 (9), 585-600, 20091682009
2-) An improved model for disease progression in patients from the Alzheimer\\\'s disease neuroimaging initiativeMN Samtani, M Farnum, V Lobanov, E Yang, N Raghavan, A DiBernardo, ...The Journal of Clinical Pharmacology 52 (5), 629-644, 2012982012
3-) The ADAS-Cog revisited: novel composite scales based on ADAS-Cog to improve efficiency in MCI and early AD trialsN Raghavan, MN Samtani, M Farnum, E Yang, G Novak, M Grundman, ...Alzheimer\\\'s & Dementia 9 (1), S21-S31, 20131002013
4-) Practical guidance for dosing and switching paliperidone palmitate treatment in patients with schizophreniaS Gopal, C Gassmann-Mayer, J Palumbo, MN Samtani, R Shiwach, ...Current medical research and opinion 26 (2), 377-387, 20101002010
5-) Dosing and switching strategies for paliperidone palmitate: based on population pharmacokinetic modelling and clinical trial dataMN Samtani, S Gopal, C Gassmann-Mayer, L Alphs, JM PalumboCNS drugs 25, 829-845, 2011892011